In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
about
The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo.Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis.Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
P2860
In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
In vivo uteroplacental release ...... and preeclamptic pregnancies.
@en
In vivo uteroplacental release ...... and preeclamptic pregnancies.
@nl
type
label
In vivo uteroplacental release ...... and preeclamptic pregnancies.
@en
In vivo uteroplacental release ...... and preeclamptic pregnancies.
@nl
prefLabel
In vivo uteroplacental release ...... and preeclamptic pregnancies.
@en
In vivo uteroplacental release ...... and preeclamptic pregnancies.
@nl
P2093
P1476
In vivo uteroplacental release ...... and preeclamptic pregnancies.
@en
P2093
Ane M Holme
Marie C P Roland
Trond M Michelsen
P304
782.e1-782.e9
P356
10.1016/J.AJOG.2016.07.056
P407
P577
2016-08-05T00:00:00Z